type here...

CATEGORIES

Cardiovascular

LATEST

123...19Page 1 of 19

TRENDING

EDITORS CHOICE

In Sudden Cardiac Death, Time Is Memory

John Nosta -
Time to defibrillation is a critical determinate of survival and neurological recovery.

Don’t Crystal Ball Patients’ Futures – AI Delivers Accuracy Right Now

Gil Bashe, Medika Life Editor -
Medika Life Talks with Ibex CEO Joseph Mossel on How AI is Changing Pathologists’ Workflow, Output and Professional Satisfaction

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

The Remarkable Research Of CAR T Therapy: B Cell Cancers

William Haseltine, PhD -
The first installment lays the foundation for understanding how CAR T works. This second piece delves into the use of CAR T to treat B cell cancers.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories